{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:33:12Z","timestamp":1725582792476},"reference-count":29,"publisher":"ALUNA","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>Aim: To study the effectiveness of BTA in a total dose of 100 IU as the preparation for patients with primary and incisional ventral hernias (VH).\nMaterials and Methods: The prospective study included 59 patients with large VH (defect \u00b310 cm). All patients received 100 IU of BTA in abdominal wall muscles 4-5 weeks before surgery from June 2017 to December 2022. An average age of the patients was 59.13 \u00b1 9.07 years, body mass index \u2013 32.20 \u00b1 4.95 kg\/m2.\nResults: An average width of the hernia defect after BTA decreased by 4.5 \u00b1 1.11 cm (p&lt;0.001). An average length of the hernia defect after BTA also decreased, without clinical significance. A significant increase in the length of the abdominal wall and a decrease in its thickness were observed. The abdominal cavity volume after BTA increased by 4.04 \u00b1 4.55% (p=0.008) and the hernial sac volume decreased by 21.43 \u00b1 16.57% (p=0.005). All patients underwent surgery with hernia defect suturing and without component separation: laparoscopic IPOM hernioplasty \u2013 50 (84.7%) patients, open IPOM hernia repair \u2013 7 (11.9%) patients, open sublay hernioplasty \u2013 2 (3.4%) patients. There was no recurrence of hernia during 12 months after surgery.\nConclusions: The administration of 100 IU BTA allows to increase the length of the abdominal wall muscles and to perform laparoscopic IPOM hernioplasty for patients with large VH.<\/jats:p>","DOI":"10.36740\/wlek202406112","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T10:38:55Z","timestamp":1722940735000},"page":"1188-1197","source":"Crossref","is-referenced-by-count":0,"title":["The use of botulinum toxin type a to prepare patients with large ventral hernias for laparoscopic hernioplasty: Our experience"],"prefix":"10.36740","volume":"77","author":[{"given":"Tetiana V.","family":"Tarasiuk","sequence":"first","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr Yu.","family":"Ioffe","sequence":"additional","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr M.","family":"Chukanov","sequence":"additional","affiliation":[{"name":"LIFESCAN-CLINIC, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mykola S.","family":"Kryvopustov","sequence":"additional","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr P.","family":"Stetsenko","sequence":"additional","affiliation":[{"name":"BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Timmer AS, Claessen JJM, Atema JJ et al. A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstruction. Hernia. 2021;25(6):1413\u20131425. doi:10.1007\/s10029-021-02499-1.","DOI":"10.1007\/s10029-021-02499-1"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. Cherla DV, Poulose B, Prabhu AS. Epidemiology and disparities in care: the impact of socioeconomic status, gender, and race on the presentation, management, and outcomes of patients undergoing ventral hernia repair. Surg Clin North Am. 2018;98(3):431-440. doi:10.1016\/j.suc.2018.02.003.","DOI":"10.1016\/j.suc.2018.02.003"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Raftopoulos I, Vanuno D, Khorsand J et al. Outcome of laparoscopic ventral hernia repair in correlation with obesity, type of hernia, and hernia size. J Laparoendosc Adv Surg Tech A. 2002;12(6):425-429. doi:10.1089\/109264202762252695.","DOI":"10.1089\/109264202762252695"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Schlosser KA, Arnold MR, Otero J et al. Deciding on optimal approach for ventral hernia repair: laparoscopic or open. J Am Coll Surg. 2019;228(1):54-65. doi:10.1016\/j.jamcollsurg.2018.09.004.","DOI":"10.1016\/j.jamcollsurg.2018.09.004"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Bittner R, Bingener-Casey J, Dietz U et al. Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society [IEHS])-part 1. Surg Endosc. 2014;28(1):2-29. doi:10.1007\/s00464-013-3170-6.","DOI":"10.1007\/s00464-013-3170-6"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Bittner R, Bingener-Casey J, Dietz U et al. Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society [IEHS])\u2014Part 2. Surg Endosc. 2014;28(2):353-379. doi:10.1007\/s00464-013-3171-5.","DOI":"10.1007\/s00464-013-3171-5"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Bittner R, Bingener-Casey J, Dietz U et al. Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society [IEHS])-Part III. Surg Endosc. 2014;28(2):380-404. doi:10.1007\/s00464-013-3172-4.","DOI":"10.1007\/s00464-013-3172-4"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Earle D, Roth JS, Saber A et al. SAGES guidelines for laparoscopic ventral hernia repair. Surg Endosc. 2016;30(8):3163-3183. doi:10.1007\/ s00464-016-5072-x.","DOI":"10.1007\/s00464-016-5072-x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Silecchia G, Campanile FC, Sanchez L et al. Laparoscopic ventral\/incisional hernia repair: updated Consensus Development Conference based guidelines [corrected] published correction appears in Surg Endosc. Surg Endosc. 2015;29(9):2485. doi:10.1007\/s00464-015-4293-8.","DOI":"10.1007\/s00464-015-4470-9"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10. Liang MK, Holihan JL, Itani K et al. Ventral hernia management: expert consensus guided by systematic review. Ann Surg. 2017;265(1):80-89. doi:10.1097\/SLA.0000000000001701.","DOI":"10.1097\/SLA.0000000000001701"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Bittner R, Bain K, Bansal VK et al. Update of Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias. (International Endohernia Society [IEHS])-Part A\u044e [published correction appears in Surg Endosc. Surg Endosc. 2019;33(10):3069-3139. doi:10.1007\/s00464-019-06907-7.","DOI":"10.1007\/s00464-013-3147-5"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Bittner R, Bain K, Bansal VK et al. Update of Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society [IEHS]): Part B. Surg Endosc. 2019);33(11):3511-3549. doi:10.1007\/s00464-019-06908-6.","DOI":"10.1007\/s00464-013-3147-5"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Kockerling F, Hoffmann H, Mayer F et al. What are the trends in incisional hernia repair? Real-world data over 10 years from the Herniamed registry. Hernia. 2021;25(2):255-265. doi:10.1007\/s10029-020-02319-y.","DOI":"10.1007\/s10029-020-02319-y"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Ibarra-Hurtado TR, Nuno-Guzman CM, Echeagaray-Herrera JE et al. Use of botulinum toxin type A before abdominal wall hernia reconstruction. World J Surg. 2009;33(12):2553\u20132556. doi:10.1007\/s00268-009-0203-3.","DOI":"10.1007\/s00268-009-0203-3"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Elhage SA, Deerenberg EB, Shao JM et al. The use of botulinum toxin A in chemical component separation: a review of techniques and outcomes. Plastic and Aesthetic Research. 2020;7:16. doi:10.20517\/2347-9264.2020.03.","DOI":"10.20517\/2347-9264.2020.03"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Wegdam JA, de Vries Reilingh TS, Bouvy ND et al. Prehabilitation of complex ventral hernia patients with Botulinum: a systematic review of the quantifiable effects of Botulinum. Hernia. 2021;25(6):1427-1442. doi:10.1007\/s10029-020-02333-0.","DOI":"10.1007\/s10029-020-02333-0"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Muysoms FE, Miserez M, Berrevoet F et al. Classification of primary and incisional abdominal wall hernias. Hernia. 2009;13(4):407\u2013414. doi:10.1007\/s10029-009-0518-x.","DOI":"10.1007\/s10029-009-0518-x"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Alam NN, Narang SK, Pathak S et al. Methods of abdominal wall expansion for repair of incisional hernia: a systematic review. Hernia. 2016;20(2):191\u2013199. doi:10.1007\/s10029-016-1463-0.","DOI":"10.1007\/s10029-016-1463-0"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Weissler JM, Lanni MA, Tecce MG et al. Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia. J Plast Surg Hand Surg. 2017;51(5):366\u2013374. doi:10.1080\/2000656X.2017.1285783.","DOI":"10.1080\/2000656x.2017.1285783"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. van Rooijen MMJ, Yurtkap Y, Allaeys M et al. Fascial closure in giant ventral hernias after preoperative botulinum toxin A and progressive pneumoperitoneum: A systematic review and meta-analysis. Surgery (United States). 2021;170(3):769\u2013776. doi:10.1016\/j.surg.2021.03.027.","DOI":"10.1016\/j.surg.2021.03.027"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Scaglione F. Conversion ratio between BotoxR, DysportR, and XeominR in clinical practice. Toxins (Basel). 2016;8(3):65. doi:10.3390\/toxins8030065.","DOI":"10.3390\/toxins8030065"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Chavez-Tostado KV, Cardenas-Lailson LE, Perez-Trigos H. Results of preoperative application of botulinum toxin type A in treatment of giant incisional hernias. Revista Hispanoamericana deHernia. 2014;2(4):145\u2013151. doi:10.1016\/j.rehah.2014.06.001.","DOI":"10.1016\/j.rehah.2014.06.001"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Zielinski MD, Kuntz M, Zhang X et al. Botulinum toxin A-induced paralysis of the lateral abdominal wall after damage-control laparotomy: a multi-institutional, prospective, randomized, placebo-controlled pilot study. J Trauma Acute care Surg. 2016;80(2):237\u2013242. doi:10.1097\/ta.00000 00000000917.","DOI":"10.1097\/ta.0000000000000917"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Mourad AP, De Robles MS, Winn RD. Low-dose pre-operative Botulinum Toxin A effectively facilitates complex ventral hernia repair: a case report and review of the literature. Medicina (Kaunas, Lithuania). 2020;57(1):14. doi:10.3390\/medicina57010014.","DOI":"10.3390\/medicina57010014"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Tang FX, Ma N, Huang E et al. Botulinum Toxin A facilitated laparoscopic repair of complex ventral hernia. Front Surg. 2022;8:803023. doi:10.3389\/fsurg.2021.803023.","DOI":"10.3389\/fsurg.2021.803023"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Rodriguez-Acevedo O, Elstner KE, Jacombs ASW et al. Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc. 2018;32(2):831\u2013839. doi:10.1007\/s00464-017-5750-3.","DOI":"10.1007\/s00464-017-5750-3"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Yurtkap Y, van Rooijen MMJ, Roels S et al. Implementing preoperative Botulinum toxin A and progressive pneumoperitoneum through the use of an algorithm in giant ventral hernia repair. Hernia. 2021;25(2):389\u2013398. doi:10.1007\/s10029-020-02226-2.","DOI":"10.1007\/s10029-020-02226-2"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Bueno-Lledo J, Carreno-Saenz O, Torregrosa- Gallud A et al. Preoperative botulinum toxin and progressive pneumoperitoneum in loss of domain hernias \u2013 our first 100 cases. Front Surg. 2020;7:3. doi:10.3389\/fsurg.2020.00003.","DOI":"10.3389\/fsurg.2020.00003"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Zielinski MD, Goussous N, Schiller HJ et al. Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen. Hernia. 2013;17(1):101\u2013107. doi:10.1007\/s10029-012-0995-1.","DOI":"10.1007\/s10029-012-0995-1"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T18:43:57Z","timestamp":1725561837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wiadomoscilekarskie.pl\/dl\/i\/pdf\/612\/df59f486b1cb6ddec12ff5d20b6764db\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202406112","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"type":"print","value":"0043-5147"}],"subject":[],"published":{"date-parts":[[2024]]}}}